vs
ARTS WAY MANUFACTURING CO INC（ARTW）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是ARTS WAY MANUFACTURING CO INC的1.8倍（$9.1M vs $5.1M），ARTS WAY MANUFACTURING CO INC净利率更高（-12.7% vs -60.3%，领先47.6%），ARTS WAY MANUFACTURING CO INC同比增速更快（-17.9% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $-1.0M），过去两年ARTS WAY MANUFACTURING CO INC的营收复合增速更高（-5.9% vs -6.7%）
雅氏威制造是美国的生产企业，主打农业机械、模块化建筑与刀具产品，旗下拥有雅氏威、雅氏威科研、美国硬质合金刀具多个品牌，该企业曾为凯斯纽荷兰代工生产原厂离心风机。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
ARTW vs PLX — 直观对比
营收规模更大
PLX
是对方的1.8倍
$5.1M
营收增速更快
ARTW
高出32.0%
-49.9%
净利率更高
ARTW
高出47.6%
-60.3%
自由现金流更多
PLX
多$2.7M
$-1.0M
两年增速更快
ARTW
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.1M | $9.1M |
| 净利润 | $-645.5K | $-5.5M |
| 毛利率 | 18.6% | 49.4% |
| 营业利润率 | -11.2% | -51.1% |
| 净利率 | -12.7% | -60.3% |
| 营收同比 | -17.9% | -49.9% |
| 净利润同比 | -177.6% | -184.8% |
| 每股收益（稀释后） | $-0.13 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARTWPLX
| Q4 25 | $5.1M | $9.1M | ||
| Q3 25 | $6.4M | $17.9M | ||
| Q2 25 | $6.3M | $15.7M | ||
| Q1 25 | $5.1M | $10.1M | ||
| Q4 24 | $6.2M | $18.2M | ||
| Q3 24 | $5.9M | $18.0M | ||
| Q2 24 | $6.7M | $13.5M | ||
| Q1 24 | $5.7M | — |
净利润ARTWPLX
| Q4 25 | $-645.5K | $-5.5M | ||
| Q3 25 | $254.1K | $2.4M | ||
| Q2 25 | $1.5M | $164.0K | ||
| Q1 25 | $-55.8K | $-3.6M | ||
| Q4 24 | $832.0K | $6.5M | ||
| Q3 24 | $-26.2K | $3.2M | ||
| Q2 24 | $-33.3K | $-2.2M | ||
| Q1 24 | $-465.0K | — |
毛利率ARTWPLX
| Q4 25 | 18.6% | 49.4% | ||
| Q3 25 | 27.5% | 53.4% | ||
| Q2 25 | 32.5% | 62.5% | ||
| Q1 25 | 29.1% | 19.1% | ||
| Q4 24 | 36.1% | 78.7% | ||
| Q3 24 | 28.9% | 53.4% | ||
| Q2 24 | 28.3% | 29.8% | ||
| Q1 24 | 25.7% | — |
营业利润率ARTWPLX
| Q4 25 | -11.2% | -51.1% | ||
| Q3 25 | 5.4% | 11.9% | ||
| Q2 25 | 8.1% | 7.5% | ||
| Q1 25 | 0.0% | -41.0% | ||
| Q4 24 | 8.4% | 39.6% | ||
| Q3 24 | 2.6% | 22.2% | ||
| Q2 24 | 2.5% | -18.0% | ||
| Q1 24 | -6.6% | — |
净利率ARTWPLX
| Q4 25 | -12.7% | -60.3% | ||
| Q3 25 | 4.0% | 13.2% | ||
| Q2 25 | 23.4% | 1.0% | ||
| Q1 25 | -1.1% | -35.8% | ||
| Q4 24 | 13.5% | 35.6% | ||
| Q3 24 | -0.4% | 18.0% | ||
| Q2 24 | -0.5% | -16.4% | ||
| Q1 24 | -8.1% | — |
每股收益（稀释后）ARTWPLX
| Q4 25 | $-0.13 | $-0.06 | ||
| Q3 25 | $0.05 | $0.03 | ||
| Q2 25 | $0.29 | $0.00 | ||
| Q1 25 | $-0.01 | $-0.05 | ||
| Q4 24 | $0.17 | $0.10 | ||
| Q3 24 | $-0.01 | $0.03 | ||
| Q2 24 | $-0.01 | $-0.03 | ||
| Q1 24 | $-0.09 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.8K | $14.7M |
| 总债务越低越好 | $2.5M | — |
| 股东权益账面价值 | $13.3M | $48.2M |
| 总资产 | $22.5M | $82.3M |
| 负债/权益比越低杠杆越低 | 0.19× | — |
8季度趋势，按日历期对齐
现金及短期投资ARTWPLX
| Q4 25 | $4.8K | $14.7M | ||
| Q3 25 | $6.0K | $13.6M | ||
| Q2 25 | $4.5K | $17.9M | ||
| Q1 25 | $4.1K | $19.5M | ||
| Q4 24 | $1.9K | $19.8M | ||
| Q3 24 | $5.1K | $27.4M | ||
| Q2 24 | $4.5K | $23.4M | ||
| Q1 24 | $2.5K | — |
总债务ARTWPLX
| Q4 25 | $2.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $2.7M | — | ||
| Q2 24 | $2.7M | — | ||
| Q1 24 | $2.7M | — |
股东权益ARTWPLX
| Q4 25 | $13.3M | $48.2M | ||
| Q3 25 | $13.9M | $52.9M | ||
| Q2 25 | $13.6M | $49.9M | ||
| Q1 25 | $12.1M | $45.2M | ||
| Q4 24 | $12.1M | $43.2M | ||
| Q3 24 | $11.3M | $32.4M | ||
| Q2 24 | $11.2M | $28.6M | ||
| Q1 24 | $11.2M | — |
总资产ARTWPLX
| Q4 25 | $22.5M | $82.3M | ||
| Q3 25 | $21.8M | $82.3M | ||
| Q2 25 | $20.9M | $78.5M | ||
| Q1 25 | $21.0M | $73.9M | ||
| Q4 24 | $21.2M | $73.4M | ||
| Q3 24 | $23.5M | $61.6M | ||
| Q2 24 | $23.2M | $91.5M | ||
| Q1 24 | $24.3M | — |
负债/权益比ARTWPLX
| Q4 25 | 0.19× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.17× | — | ||
| Q3 24 | 0.24× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.24× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-889.2K | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $-1.0M | $1.6M |
| 自由现金流率自由现金流/营收 | -20.6% | 17.8% |
| 资本支出强度资本支出/营收 | 3.0% | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.5M | $-13.6M |
8季度趋势，按日历期对齐
经营现金流ARTWPLX
| Q4 25 | $-889.2K | $2.0M | ||
| Q3 25 | $-1.3M | $-3.7M | ||
| Q2 25 | $1.4M | $-5.2M | ||
| Q1 25 | $-101.8K | $-5.1M | ||
| Q4 24 | $1.2M | $4.0M | ||
| Q3 24 | $282.4K | $4.1M | ||
| Q2 24 | $1.2M | $-3.6M | ||
| Q1 24 | $-99.3K | — |
自由现金流ARTWPLX
| Q4 25 | $-1.0M | $1.6M | ||
| Q3 25 | $-1.5M | $-4.2M | ||
| Q2 25 | $1.2M | $-5.7M | ||
| Q1 25 | $-184.5K | $-5.4M | ||
| Q4 24 | $1.1M | $3.6M | ||
| Q3 24 | $180.5K | $4.0M | ||
| Q2 24 | $1.0M | $-3.8M | ||
| Q1 24 | $-380.4K | — |
自由现金流率ARTWPLX
| Q4 25 | -20.6% | 17.8% | ||
| Q3 25 | -23.8% | -23.7% | ||
| Q2 25 | 19.3% | -36.2% | ||
| Q1 25 | -3.6% | -53.0% | ||
| Q4 24 | 17.6% | 19.6% | ||
| Q3 24 | 3.1% | 22.4% | ||
| Q2 24 | 15.1% | -28.1% | ||
| Q1 24 | -6.6% | — |
资本支出强度ARTWPLX
| Q4 25 | 3.0% | 4.4% | ||
| Q3 25 | 4.1% | 2.8% | ||
| Q2 25 | 2.1% | 2.8% | ||
| Q1 25 | 1.6% | 3.0% | ||
| Q4 24 | 1.8% | 2.3% | ||
| Q3 24 | 1.7% | 0.5% | ||
| Q2 24 | 3.4% | 1.3% | ||
| Q1 24 | 4.9% | — |
现金转化率ARTWPLX
| Q4 25 | — | — | ||
| Q3 25 | -4.99× | -1.58× | ||
| Q2 25 | 0.91× | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.44× | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARTW
| Agricultural Products | $2.8M | 55% |
| Modular Buildings | $2.2M | 44% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
